SCHEMBL28068645

SCHEMBL28068645

CCC(=O)Oc1c(Cl)cccc1I

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.42
ACHE P22303 1/20 0.40
ELANE P08246 1/20 0.38
ESR1 P03372 2/20 0.38
HIF1A Q16665 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
RECQL P46063 1/20 0.38
NLRP3 Q96P20 1/20 0.37
PTPN7 P35236 1/20 0.37
PTPN12 Q05209 1/20 0.37
PTPN22 Q9Y2R2 1/20 0.37
ALDH1A1 P00352 2/20 0.36
ACLY P53396 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TTR P02766 1/20 0.35
AKR1B1 P15121 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2898218 0.88 KMT2A (0.48) KMT2AACHEELANEESR1HIF1A
SCHEMBL15548823 0.81 ACHE (0.41) KMT2AACHEELANEESR1HIF1A
SCHEMBL15547750 0.81 KMT2A (0.43) KMT2AACHEELANEESR1HIF1A
SCHEMBL3529575 0.81 SMN1; SMN2 (0.50) KMT2AACHEELANEESR1HIF1A
SCHEMBL28068587 0.81 KMT2A (0.43) KMT2AACHEELANEESR1HIF1A
SCHEMBL7389800 0.80 ACHE (0.43) KMT2AACHEELANEESR1HIF1A
SCHEMBL28832125 0.80 ACHE (0.43) KMT2AACHEELANEESR1HIF1A
SCHEMBL7508588 0.80 SMN1; SMN2 (0.43) KMT2AACHEELANESMN1; SMN2ALDH1A1
SCHEMBL2399695 0.79 ALDH1A1 (0.43) KMT2AACHESMN1; SMN2ALDH1A1LMNA
Hydrochloric Acid SCHEMBL27997324 0.79 ACHE (0.42) KMT2AACHEELANEESR1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103687860-B As P2X7Heterocyclic amide derivatives of receptor antagonists 埃科特莱茵药品有限公司 2016-06-08 CN disclosed